Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001771961-25-000006

Chief Accounting Officer sold 2,831 shares at $13.00 ($36,803)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-29 Sale : show line 1 in the form 10b5-1 −2,831 $13.00 $36,803 27,363 D
Open-market sales · 2,831 sh · avg $13.00 · $36,803
Loading xslF345X05/wk-form4_1759273140.xml…